About us
The Infected Blood Compensation Authority (IBCA) will deliver the Infected Blood Compensation Scheme, which will provide financial compensation to victims of infected blood on a UK-wide basis. The Scheme responds to the recommendations made by the Infected Blood Inquiry in its second interim report, and the earlier study into compensation by Sir Robert Francis KC.
In July 2017, the Government announced the Infected Blood Inquiry under the Inquiries Act 2005, with Sir Brian Langstaff as its Chair. Over the past six years, the Inquiry has examined the circumstances in which men, women and children treated by the NHS in the UK were given infected blood and blood products, in particular since 1970. The Inquiry has given voice to the heartbreaking experiences of those infected and affected by the scandal. The Inquiry published its final report on 20 May 2024.
The goal of the Infected Blood Compensation Authority (IBCA) is to ensure that compensation payments are made as swiftly as possible. It is currently part of the Cabinet Office in its shadow form, but will become an established legal entity once the relevant legislation is passed.
The Prime Minister acknowledged the publication of the Inquiry’s report in a statement to the House of Commons on 20 May 2024. On 21 May 2024, The Minister for the Cabinet Office announced the Infected Blood Compensation Scheme and a further set of interim payments to living infected persons.
There will be further updates to this page leading up to the full establishment of the IBCA and the operationalisation of the compensation scheme.
Governance of the Shadow IBCA:
- Sir Robert Francis KC, Interim Chair
- David Foley, Interim Chief Executive Officer